Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q2 FY20 results · Jul–Sep 2019
Divi's Laboratories reported revenue from operations of ₹1,445.57 crore and net profit of ₹356.78 crore for Q2 FY20 (Jul–Sep 2019), on a consolidated basis.
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,445.57 | — | — | 1,162.88 | +24.3% |
| Other income | 47.03 | — | — | 30.32 | +55.1% |
| Total income | 1,492.60 | — | — | 1,193.20 | +25.1% |
| Profit before tax | 487.87 | — | — | 373.31 | +30.7% |
| Net profit for the period | 356.78 | — | — | 272.44 | +31.0% |
| EPS, basic (₹) | 13.44 | — | — | 10.26 | +31.0% |
| Net margin (%) | 24.7 | — | 23.4 |
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,403.92 | 1,285.00 | +9.3% | 1,139.92 | +23.2% |
| Other income | 47.36 | 80.05 | −40.8% | 31.63 | +49.7% |
| Total income | 1,451.28 | 1,365.05 | +6.3% | 1,171.55 | +23.9% |
| Profit before tax | 483.02 | 551.55 | −12.4% | 366.11 | +31.9% |
| Net profit for the period | 352.83 | 397.65 | −11.3% | 267.35 | +32.0% |
| EPS, basic (₹) | 13.29 | 14.98 | −11.3% | 10.07 | +32.0% |
| Net margin (%) | 25.1 | 30.9 | 23.5 |
Consolidated
- Filed with BSE
- 06 Nov 2019, 10:16 IST
- Board meeting
- 05 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 06 Nov 2019, 10:16 IST
- Board meeting
- 05 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE